Drug interactions between cyclophosphamide and pomalidomide
Interactions between your drugs
There were no interactions found in our database between cyclophosphamide and pomalidomide - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Cyclophosphamide is in the drug class alkylating agents.
- Cyclophosphamide is used to treat the following conditions:
- Acute Lymphocytic Leukemia
- Acute Nonlymphocytic Leukemia
- Bladder Cancer
- Brain Tumor
- Breast Cancer
- Bullous Pemphigoid
- Cervical Cancer
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Cogan's Syndrome
- Diffuse Large B-Cell Lymphoma
- Endometrial Cancer
- Ewing's Sarcoma
- Granulomatosis with Polyangiitis
- Hodgkin's Lymphoma
- IgA Nephropathy
- Mantle Cell Lymphoma
- Multiple Myeloma
- Multiple Sclerosis
- Mycosis Fungoides
- Nephrotic Syndrome
- Non-Hodgkin's Lymphoma
- Non-Small Cell Lung Cancer
- Organ Transplant, Rejection Prophylaxis
- Ovarian Cancer
- Prostate Cancer
- Rheumatoid Arthritis
- Small Cell Lung Cancer
- Systemic Lupus Erythematosus
- Systemic Sclerosis
- Testicular Cancer
- Wilms' Tumor
- Pomalidomide is a member of the following drug classes: miscellaneous antineoplastics, other immunosuppressants.
- Pomalidomide is used to treat Multiple Myeloma.
Drug and food interactions
Applies to: pomalidomide
If you are a smoker, you should be aware that cigarette smoking may reduce the blood levels and effects of pomalidomide. Talk to your health care professional if you have any questions or concerns. Pomalidomide should be taken with water the same time everyday on an empty stomach, at least 2 hours before or 2 hours after a meal. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No therapeutic duplications were found for your selected drugs.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.